Basic Pharma Manufacturing
Our manufacturing division executes the operations of production, quality control (laboratory), quality assurance, supply chain and sales. Its facilities include certified clean rooms in classes B, C and D, where pharmaceutical products are prepared by batch processing, from compounding to finishing and filling into primary packed products. 

In our GMP-controlled clean rooms, we are able to provide a wide range of services with respect to investigational medicinal products (IMPs) such as fill and finish of solutions for injections (aseptic if needed), including cytotoxic compounds, blinding of study medications, randomisation, packaging and labelling of clinical trial medications and more.

Basic Pharma Manufacturing also possesses the relevant permits for processing and manufacturing.

Its production lines are equipped with state-of-the-art machinery for the processing of liquids, suspensions, creams and ointments into finished pharmaceutical products, which are generally commercialised under a private label. We are able to manufacture sterile and non-sterile products (including pre-filled syringes and vials) and to handle high potency compounds.

Subsequently, the intermediate primary packed products are labelled and packed in adjacent facilities on automated labelling and packing lines. Our company made an early start in preparation for the new European regulations regarding serialisation that take effect in February 2019, allowing it to be ready ahead of schedule to meet the new requirements.  

The manufacturing company operates as a Contract Manufacturing Organisation (see CMO Services), both for its own organisation (producing products for Basic Pharma Technologies), and for commercial partners. Basic Pharma Manufacturing operates a specialist department for handling investigational medicinal products (see IMP Services). This department formulates, fills and packs products for a variety of clients, including academic research centres and pharmaceutical/biotech companies.

The quality control laboratory primarily performs quality control on Basic Pharma products but also acts as a contract laboratory for third parties (see Laboratory Services). The quality department has experienced professionals who are also available to provide professional services to others (see Quality Services).

Basic Pharma Technologies 
Our development division runs product development projects for the entire gamut from generic to innovative medicines. Multiple development projects are being coordinated and executed at any given time, including co-financed projects. The successful completion of such projects culminates in product registrations in various countries. The activities of Basic Pharma Technologies are aimed at growing the current product pipeline. In this process Interdos submits product dossiers for filing and registration in several markets, while our manufacturing division handles production and distribution. With this comprehensive package of services, the group’s activities cover the entire chain from product development through to production, up to and including sales and distribution.  

In 2017 the ‘SKiN-Huid’ programme was launched, an early development project, with several partners, to develop and manufacture a drug to fight skin tumours. The programme is being subsidised by the European Union (Interreg Flanders-Netherlands), with additional sponsorship from the Province of Limburg and the Dutch Ministry of Economic Affairs. The role of Basic Pharma Technologies in this is to set up a biotech manufacturing unit and develop a GMP manufacturing process to produce an investigational medicinal drug to fight skin tumours.  

Interdos
The group’s consultancy firm, Interdos, provides tailor-made services to a wide range of customers and business partners in the pharmaceutical supply chain. This includes the internal clients, Basic Pharma Manufacturing and Basic Pharma Technologies, as well as external (international) clients and partners. Interdos is mainly active in the following fields of expertise: regulatory affairs (activities related to maintaining existing and adding new product registrations in several territories), pharmacovigilance (monitoring adverse reactions to medicines) and quality affairs (wide range of activities aimed at ensuring quality, such as batch release by a Qualified Person, assistance in obtaining licenses and training). With its broad base of expertise, the company serves both local and international clients and has built an extensive track record. For more information on Interdos, please consult their website.